Immunovia AB (publ) (IMMVF)
USD 0.07
(0.0%)
USD 0.07
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -309.43 Million SEK | -84.09% |
| 2022 | -168.09 Million SEK | -7.77% |
| 2021 | -155.96 Million SEK | -6.8% |
| 2020 | -146.03 Million SEK | -27.52% |
| 2019 | -114.52 Million SEK | -32.33% |
| 2018 | -86.53 Million SEK | -91.32% |
| 2017 | -45.23 Million SEK | -207.22% |
| 2016 | -14.72 Million SEK | -99.4% |
| 2015 | -7.38 Million SEK | 16.65% |
| 2014 | -8.85 Million SEK | -454.94% |
| 2013 | -1.59 Million SEK | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -25.59 Million SEK | -768.87% |
| 2024 Q1 | -2.94 Million SEK | 93.99% |
| 2023 Q3 | -38.55 Million SEK | 77.35% |
| 2023 Q4 | -49.02 Million SEK | -27.14% |
| 2023 FY | -309.43 Million SEK | -84.09% |
| 2023 Q1 | -51.65 Million SEK | 23.27% |
| 2023 Q2 | -170.2 Million SEK | -229.48% |
| 2022 Q3 | -22.93 Million SEK | 32.0% |
| 2022 Q2 | -33.72 Million SEK | 23.54% |
| 2022 Q1 | -44.11 Million SEK | 6.4% |
| 2022 FY | -168.09 Million SEK | -7.77% |
| 2022 Q4 | -67.32 Million SEK | -193.57% |
| 2021 Q1 | -23.44 Million SEK | 49.16% |
| 2021 Q3 | -36.13 Million SEK | 26.65% |
| 2021 Q2 | -49.26 Million SEK | -110.11% |
| 2021 FY | -155.96 Million SEK | -6.8% |
| 2021 Q4 | -47.12 Million SEK | -30.44% |
| 2020 Q1 | -27.75 Million SEK | 14.91% |
| 2020 Q2 | -34.09 Million SEK | -22.87% |
| 2020 Q3 | -38.06 Million SEK | -11.63% |
| 2020 Q4 | -46.11 Million SEK | -21.16% |
| 2020 FY | -146.03 Million SEK | -27.52% |
| 2019 Q4 | -32.61 Million SEK | -27.28% |
| 2019 Q1 | -26.38 Million SEK | -2.84% |
| 2019 Q3 | -25.62 Million SEK | 14.29% |
| 2019 Q2 | -29.89 Million SEK | -13.31% |
| 2019 FY | -114.52 Million SEK | -32.33% |
| 2018 Q2 | -26.15 Million SEK | -50.95% |
| 2018 Q1 | -17.32 Million SEK | -13.11% |
| 2018 Q3 | -17.4 Million SEK | 33.46% |
| 2018 Q4 | -25.65 Million SEK | -47.42% |
| 2018 FY | -86.53 Million SEK | -91.32% |
| 2017 Q2 | -10.55 Million SEK | -35.81% |
| 2017 Q3 | -11.58 Million SEK | -9.81% |
| 2017 Q4 | -15.31 Million SEK | -32.18% |
| 2017 FY | -45.23 Million SEK | -207.22% |
| 2017 Q1 | -7.77 Million SEK | -44.52% |
| 2016 Q4 | -5.37 Million SEK | -32.84% |
| 2016 Q3 | -4.04 Million SEK | -39.97% |
| 2016 Q2 | -2.89 Million SEK | -20.2% |
| 2016 Q1 | -2.4 Million SEK | -34.54% |
| 2016 FY | -14.72 Million SEK | -99.4% |
| 2015 Q2 | -1.9 Million SEK | 0.0% |
| 2015 Q3 | -1.78 Million SEK | 6.05% |
| 2015 Q4 | -1.78 Million SEK | 0.0% |
| 2015 FY | -7.38 Million SEK | 16.65% |
| 2015 Q1 | -1.9 Million SEK | 36.79% |
| 2014 Q4 | -3.01 Million SEK | 0.0% |
| 2014 FY | -8.85 Million SEK | -454.94% |
| 2014 Q1 | -1.41 Million SEK | 0.0% |
| 2014 Q2 | -1.41 Million SEK | 0.0% |
| 2014 Q3 | -3.01 Million SEK | -112.39% |
| 2013 FY | -1.59 Million SEK | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.41 Million USD | -21846.028% |
| Arrayit Corporation | -3.31 Million USD | -9232.837% |
| Atlantic International Corp. | -5.62 Million USD | -5398.605% |
| Biocept, Inc. | -32.08 Million USD | -864.375% |
| Bioqual, Inc. | 483.48 Thousand USD | 64102.308% |
| CardioGenics Holdings Inc | -1.91 Million USD | -16047.53% |
| DermTech, Inc. | -100.88 Million USD | -206.715% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.02 Billion USD | 115.282% |
| HTG Molecular Diagnostics, Inc. | -21.59 Million USD | -1332.954% |
| iMD Companies, Inc. | -200.63 Thousand USD | -154129.052% |
| IDenta Corp. | 14.64 Thousand USD | 2113177.028% |
| Interpace Biosciences, Inc. | 802 Thousand USD | 38683.416% |
| Integrative Health Technologies, Inc. | 38.68 Thousand USD | 799911.316% |
| InVitro International | 1553.00 USD | 19925341.468% |
| Lumos Diagnostics Holdings Limited | -8.59 Million USD | -3501.478% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -532387.266% |
| Medical Imaging Corp. | -3.02 Million USD | -10136.075% |
| NovelStem International Corp. | -4.18 Million USD | -7289.941% |
| Optigenex Inc. | -2.89 Million USD | -10578.559% |
| PharmChem, Inc. | 845.1 Thousand USD | 36715.58% |
| Proteome Sciences plc | -2.44 Million USD | -12566.353% |
| Response Genetics, Inc | -20.18 Million USD | -1433.091% |
| Rennova Health, Inc. | -3.29 Million USD | -9296.715% |
| RushNet, Inc. | -607.02 Thousand USD | -50876.067% |
| ScreenPro Security Inc. | -2.24 Million USD | -13660.385% |
| Stella Diagnostics Inc. | -5.7 Million USD | -5321.689% |
| StageZero Life Sciences Ltd. | -11.41 Million USD | -2610.722% |
| Todos Medical Ltd. | -24.99 Million USD | -1138.053% |